Abstract-L-type calcium channels (Ca v 1.m) inactivate in response to elevation of intracellular Ca 2ϩ (Ca 2ϩ -dependent inactivation) and additionally by conformational changes induced by membrane depolarization (fast and slow voltage-dependent inactivation). Molecular determinants of inactivation play an essential role in channel inhibition by phenylalkylamines (PAAs). The relative impacts, however, of Ca 2ϩ -dependent and voltage-dependent inactivation in Ca v 1.2 sensitivity for PAAs remain unknown. In order to analyze the role of the different inactivation processes, we expressed Ca v 1.2 constructs composed of different -subunits ( 1a -,  2a -, or  3 -subunit) in Xenopus oocytes and estimated their (-)gallopamil sensitivity by means of the two-microelectrode voltage clamp with either Ba 2ϩ or Ca 2ϩ as charge carrier. Ca v 1.2 consisting of the  2a -subunit displayed the slowest inactivation and the lowest apparent sensitivity for the PAA (-)gallopamil. A significantly higher apparent (-)gallopamil-sensitivity with Ca 2ϩ as charge carrier was observed for all 3 -subunit compositions. The kinetics of Ca 2ϩ -dependent inactivation and slow voltage-dependent inactivation were not affected by drug. The higher sensitivity of the Ca v 1.2 channels for (-)gallopamil with Ca 2ϩ as charge carrier results from slower recovery ( rec,Ca Ϸ15 seconds versus rec,Ba Ϸ3 to 5 seconds) from a PAA-induced channel conformation. We propose a model where (-) antagonists, ie, phenylalkylamines (PAAs), benzothiazepines (ie, diltiazem) and 1,4-dihydropyridines (DHPs). [2][3][4][5] About 20 years ago, several groups demonstrated that Ca v 1.m inhibition by PAAs and diltiazem occurs predominately during membrane depolarizations ("use-dependent" action) when the channels are primarily in the open or inactivated conformation. [2][3][4]6 Since then, numerous studies in myocardial and smooth muscle cells have shown that Ca 2ϩ channel inhibition by these compounds, as well as by the new compound mibefradil, reflect a balance between channel shut-off during membrane depolarization and subsequent recovery at rest. [7][8][9][10][11] Over the last three years there has been substantial progress toward understanding the role of inactivation in Ca 2ϩ channel inhibition by Ca 2ϩ antagonists. Site directed mutagenesis enabled a detailed analysis of the impact of this process in PAA sensitivity. A comparison of the PAA sensitivities of Ca v 2.1 mutants and chimeric channel constructs inactivating at different rates revealed a strong correlation between the rates of fast voltage-dependent inactivation and apparent PAA sensitivities. 11-13 Similar findings were reported for Ca 2ϩ channel block by diltiazem. 11,14 Subsequently, the studies concentrated on the localization of inactivation determinants that are relevant for channel inhibition. Thus, inactivation determinants in the loop between domains I and II and -subunit interaction have been shown to control PAA sensitivity of a Ca v 2.1 mutant 13 as well as the mibefradilsensitivity of wild ...